yes, that bit confused me too. The $3.04m = cash receipts (which we saw was in FY20 Receivables)...but they also say "Revenue for Q1 FY21 (unaudited) approx $2.5m"
And in the Appendix we see the cash receipt total only showing ($3.036m), right?
So, how are they counting past receivables as Q1 new revenue? OR is this all completely different...they haven't collected the past receivables at all..and the $2.5m is all 'new' revenue...which means the FY20 receivables is still pending?
The ann says only AccBio 259.2k devices ordered for initial stockpile...but they would presumably have sold some for HIV, FebriDx, whatever else....
Hmm...
I think I might write to AT1 and ask for clarification around the FY20 receivables status...is it in here or not?
- Forums
- ASX - By Stock
- AT1
- Ann: Quarterly Activity Report & Appendix 4C - 30 September 2020
Ann: Quarterly Activity Report & Appendix 4C - 30 September 2020, page-16
-
-
- There are more pages in this discussion • 74 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AT1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.0¢ |
Change
-0.001(4.76%) |
Mkt cap ! $12.78M |
Open | High | Low | Value | Volume |
2.1¢ | 2.1¢ | 2.0¢ | $62 | 3.06K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 128766 | 2.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 55000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 128766 | 0.020 |
5 | 604260 | 0.019 |
9 | 1162558 | 0.018 |
3 | 410000 | 0.017 |
1 | 62561 | 0.016 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 55000 | 1 |
0.023 | 100000 | 1 |
0.024 | 431111 | 2 |
0.025 | 459000 | 2 |
0.026 | 1590045 | 4 |
Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
Featured News
AT1 (ASX) Chart |